Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2009 1
2012 1
2014 1
2015 1
2016 2
2018 2
2019 6
2020 8
2021 6
2022 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Free article. Clinical Trial.
The mortality rate from self-harm in Iran.
Ghodsi Z, Moghaddam SS, Vezvaei P, Yoosefi M, Rezaei N, Saadat S, Sheidaei A, Sharif-Alhoseini M, Sadeghian F, Ahmadi N, Jazayeri SB, Salamati P, Khosravi A, Moradi-Lakeh M, Mokdad AH, O'Reilly G, Rahimi-Movaghar V. Ghodsi Z, et al. Public Health. 2020 Sep;186:44-51. doi: 10.1016/j.puhe.2020.06.015. Epub 2020 Aug 5. Public Health. 2020. PMID: 32768623
The overall age-standardized mortality rate decreased from 4.32 per 100,000 (95% unit interface (UI): 3.25-5.75) to 2.78 (2.15-3.59) per 100,000 between 1990 and 2015, a reduction of approximately 35.65%. The M/F ratio was 2.03:1 with an annual percent change of -2.38% and …
The overall age-standardized mortality rate decreased from 4.32 per 100,000 (95% unit interface (UI): 3.25-5.75) to 2.78 (2.15-3.59) per 100 …
Impact of Bariatric Surgery on Carotid Intima-Media Thickness in Patients with Morbid Obesity: a Prospective Study and Review of the Literature.
Nabavi N, Ghodsi A, Rostami R, Torshizian A, Jamialahmadi T, Jangjoo A, Nematy M, Bahari A, Ebrahimzadeh F, Mahmoudabadi E, Khadem-Rezaiyan M, Rajabzadeh F, Goshayeshi L. Nabavi N, et al. Obes Surg. 2022 May;32(5):1563-1569. doi: 10.1007/s11695-022-05976-3. Epub 2022 Mar 2. Obes Surg. 2022. PMID: 35237906 Review.
Body mass index (BMI) was significantly reduced from 43.66 6.44 to 29.01 2.56 kg/m(2) during 6 months following surgery (p: 0.001). The mean CIMT values at 6 months after surgery were significantly lower than the baseline (0.53 0.06 vs. 0.50 0.08; p: 0.001). ...
Body mass index (BMI) was significantly reduced from 43.66 6.44 to 29.01 2.56 kg/m(2) during 6 months following surgery (p: 0.001). T …
Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents.
Shakour N, Sahebkar A, Karimi G, Paseban M, Tasbandi A, Mosaffa F, Tayarani-Najaran Z, Ghodsi R, Hadizadeh F. Shakour N, et al. Bioorg Chem. 2021 Oct;115:105162. doi: 10.1016/j.bioorg.2021.105162. Epub 2021 Jul 13. Bioorg Chem. 2021. PMID: 34314919
A newly designed series of imidazolyl-methyl- l-2,4-thiazolidinediones 9 (a-m) were synthesized and In Silico studies were carried out to rationalize their anti-diabetic activity. ...
A newly designed series of imidazolyl-methyl- l-2,4-thiazolidinediones 9 (a-m) were synthesized and In Silico studies were carried ou …
Deep learning enables de novo peptide sequencing from data-independent-acquisition mass spectrometry.
Tran NH, Qiao R, Xin L, Chen X, Liu C, Zhang X, Shan B, Ghodsi A, Li M. Tran NH, et al. Nat Methods. 2019 Jan;16(1):63-66. doi: 10.1038/s41592-018-0260-3. Epub 2018 Dec 20. Nat Methods. 2019. PMID: 30573815
We use neural networks to capture precursor and fragment ions across m/z, retention-time, and intensity dimensions. They are then further integrated with peptide sequence patterns to address the problem of highly multiplexed spectra. ...
We use neural networks to capture precursor and fragment ions across m/z, retention-time, and intensity dimensions. They are then fur …
Effect of Nonthermal Plasma on Shear Bond Strength of Translucent Zirconia in Layering Ceramic.
Seyedi D, Valizadeh S, Ghodsi S, Salimi K, Atri F. Seyedi D, et al. Int J Dent. 2023 May 15;2023:6639030. doi: 10.1155/2023/6639030. eCollection 2023. Int J Dent. 2023. PMID: 37223394 Free PMC article.
In this experimental study, 42 square blocks of zirconia were prepared and randomly divided into three groups (n = 14) according to the applying surface treatment: (1) the control group (without any surface treatment), (2) the plasma-treated group with argon nonthermal plasma, an …
In this experimental study, 42 square blocks of zirconia were prepared and randomly divided into three groups (n = 14) according to the appl …
Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
Rahimzadeh Oskuei S, Mirzaei S, Reza Jafari-Nik M, Hadizadeh F, Eisvand F, Mosaffa F, Ghodsi R. Rahimzadeh Oskuei S, et al. Bioorg Chem. 2021 Jul;112:104904. doi: 10.1016/j.bioorg.2021.104904. Epub 2021 Apr 20. Bioorg Chem. 2021. PMID: 33933802
The flow cytometry analysis of A549 cancer cells treated with 9g and 9j' displayed that these compounds induced cell cycle arrest at the G2/M phase at low concentrations and increased the number of apoptotic cells (cells in subG1 phase) at higher concentrations. ...
The flow cytometry analysis of A549 cancer cells treated with 9g and 9j' displayed that these compounds induced cell cycle arrest at the G2/ …
Anti-oxidant and anti-inflammatory effects of auraptene on phytohemagglutinin (PHA)-induced inflammation in human lymphocytes.
Askari VR, Rahimi VB, Zargarani R, Ghodsi R, Boskabady M, Boskabady MH. Askari VR, et al. Pharmacol Rep. 2021 Feb;73(1):154-162. doi: 10.1007/s43440-020-00083-5. Epub 2020 Mar 12. Pharmacol Rep. 2021. PMID: 32166733

PHA markedly elevated ROS, MDA, IL-6, and TNF-alpha levels, while diminished the GSH content, and CAT and SOD activities in human lymphocytes (p < 0.001 for all cases). Treatment with auraptene (10-90 M) significantly ameliorated ROS, MDA, IL-6, and TNF-alpha levels, an

…
PHA markedly elevated ROS, MDA, IL-6, and TNF-alpha levels, while diminished the GSH content, and CAT and SOD activities in human lymphocyte …
30 results